Cargando…
FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis
BACKGROUND: With millions of victims worldwide, multiple sclerosis is the second most common cause of disability among young adults. Although formidable advancements have been made in understanding the disease, the neurodegeneration associated with multiple sclerosis is only partially counteracted b...
Autores principales: | Zhang, Qingxiang, Chen, Zhiguo, Zhang, Kaili, Zhu, Jie, Jin, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173727/ https://www.ncbi.nlm.nih.gov/pubmed/36924298 http://dx.doi.org/10.1111/cns.14176 |
Ejemplares similares
-
COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020) -
Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007) -
Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018) -
Genetic Basis of Inflammatory Demyelinating Diseases of the Central Nervous System: Multiple Sclerosis and Neuromyelitis Optica Spectrum
por: Ortiz, Genaro Gabriel, et al.
Publicado: (2023) -
Type 2 Inflammatory Responses in Autoimmune Demyelination of the Central Nervous System: Recent Advances
por: Costanza, Massimo
Publicado: (2019)